FeesSafety
Pluang+

Bitcoin can move huge sums cheaply anytime, threatening banks' business, says Eric Trump.

Market News
04 Nov 2026, 18:13 WIB
Crypto Briefing
View Source
Neutral
Bitcoin can move huge sums cheaply anytime, threatening banks' business, says Eric Trump.

Eric Trump argues that Bitcoin's ability to transfer large amounts of money quickly and with minimal fees challenges traditional banks, which operate only during business hours and rely on intermediaries that add costs. He highlights examples like sending $500 million on a Sunday night or $1 million instantly with almost no fees. Trump, co-founder of American Bitcoin Corp., promotes Bitcoin as a more efficient alternative to banking, though his commercial interests align with this message. This ongoing advocacy underscores Bitcoin's potential impact on the financial sector.

Eric Trump's comments on Bitcoin's low transfer fees come as the cryptocurrency market shows strong breadth on Pluang, with 45 of 50 major cryptocurrencies rising today. Notable movers include BAL (Balancer) up 11.14% to Rp16.297 with a typical hold time of 85 days, BAT (Basic Attention Token) up 10.97% to Rp2.546 despite a 78% sell order activity, and EOS (EOS.IO) up 8.13% to Rp12.649 with a typical hold time of 87 days. This snapshot is as of Nov 04, 2026 22:22 WIB.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
26 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
26 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
26 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
26 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
26 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App